No insider purchase over the last 90 days. The latest, by Cant Elena, was filed 28 Aug 2023.
This page follows insider dealings at Societal CDMO, Inc. as filed with SEC (Form 4), a company from the Technology sector. Nothing new has been filed by managers of Societal CDMO, Inc. in twelve months, the latest record being from 8 April 2024.
Since 2017, the database holds 27 purchases and 29 sales by insiders of the company.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2023 · cache
25 of 232 declarations
Societal CDMO, Inc. is a company focused on the development and manufacturing of pharmaceutical products. It primarily operates in the health technology market.
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2023 | 94.6 m USD | -13.3 m USD | -0.14 USD | 10-K |
| Dec 2022 | 90.2 m USD | -19.9 m USD | -0.34 USD | 10-K |
| Dec 2021 | 75.4 m USD | -11.4 m USD | -0.26 USD | 10-K |
| Dec 2020 | 66.5 m USD | -27.5 m USD | -1.16 USD | 10-K |
| Dec 2019 | 99.2 m USD | -18.6 m USD | -0.79 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.